Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph phase_3
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
3(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 33 (100.0%)

Trials by Status

recruiting3100%

Recent Activity

3 active trials
Showing 3 of 3
recruitingphase_3

Effect GnRH Agonist Administration in Endometriosis Cyst Patients

NCT06525155
recruitingphase_3

Use of GnRHa During Chemotherapy for Fertility Protection

NCT05328258
recruitingphase_3

SRT Versus SRT+ADT in Prostate Cancer

NCT05019846

Clinical Trials (3)

Showing 3 of 3 trials
NCT06525155Phase 3

Effect GnRH Agonist Administration in Endometriosis Cyst Patients

Recruiting
NCT05328258Phase 3

Use of GnRHa During Chemotherapy for Fertility Protection

Recruiting
NCT05019846Phase 3

SRT Versus SRT+ADT in Prostate Cancer

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3